Bravex

Quick links to important sections

Bravex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bravex

Property Description
Active ingredient Ibuprofen
Form Tablets, capsules, oral suspension
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief of pain, fever, and inflammation
Origin Synthetic propionic acid derivative

Bravex is a well-established pharmaceutical product defined by its sole active ingredient, Ibuprofen (INN). The medicine is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), a group clinically recognized for its ability to reduce pain, fever, and inflammation simultaneously. Its chemical basis is a synthetic compound belonging to the propionic acid derivative class.

Composition and Presentation: What is Bravex Made of?

Bravex is manufactured as a single-ingredient product, containing only Ibuprofen, which is typically present as a racemic mixture of its enantiomers. The drug is intended for the oral route of administration.

It is widely available in multiple common dosage forms, including tablets, sealed capsules (which may be liquid-filled), and oral suspension. This array of formulations, offered in both over-the-counter (OTC) and prescription strength versions, ensures adaptability for general population use. Oral Ibuprofen is used in managing acute pain.

General Purpose: What Symptoms Does Bravex Relieve?

The essential function of Bravex is to provide comprehensive relief by targeting the three primary symptoms of acute discomfort: pain, fever, and inflammation. Its action is achieved by interrupting the synthesis of prostaglandins, the endogenous chemical signals that mediate these physiological responses.

By blocking the creation of these inflammatory mediators, the drug ensures that its analgesic, antipyretic, and anti-inflammatory properties are activated at the source of the symptoms. This mechanism provides broad utility for managing acute symptomatic discomfort, such as the temporary relief of a tension headache or muscle ache. Ibuprofen is categorized as an essential medicine, confirming the drug's fundamental utility in reducing discomfort and regulating elevated body temperature.

Regulatory References

  1. NIH StatPearls: Ibuprofen
  2. MedlinePlus: Ibuprofen Drug Information
  3. WHO Essential Medicines List
  4. WHO eEML Ibuprofen Entry

What side effects are possible with Bravex?

Possible Side Effects and Safety Information

The safety profile of Bravex (Ibuprofen) is formally documented in regulatory labels, which classify possible adverse reactions by frequency and the body system affected. While common reactions are generally non-serious, official warnings highlight specific, severe risks primarily related to the cardiovascular and gastrointestinal systems.

Adverse Reaction Categories

Side effects are categorized by how often they may occur, according to the official regulatory framework:

  • Common Reactions: These may affect up to 1 in 10 people and typically involve gastrointestinal disturbances, such as dyspepsia, nausea, and abdominal pain. Headache and dizziness are also commonly reported effects.
  • Uncommon to Rare Reactions: These include gastrointestinal ulceration, hypersensitivity reactions, visual disturbances, and the rare occurrence of aseptic meningitis or severe liver dysfunction.

Serious Adverse Reactions and Systemic Risks

Official government labels specify potentially life-threatening risks that, while uncommon, are associated with the use of this NSAID:

  • Cardiovascular Thrombotic Events: An increased risk of serious, sometimes fatal, events, including myocardial infarction and stroke, is documented. This risk may increase with higher doses and longer duration of use.
  • Gastrointestinal Complications: Serious adverse events, such as gastrointestinal bleeding, ulceration, or perforation, can occur at any time during treatment, often without prior warning symptoms. Older adults face a greater risk of these serious events.

Safety Considerations and Limitations

Use is officially restricted for individuals with pre-existing conditions, including severe heart, renal, or hepatic failure, and those with active gastrointestinal bleeding or a history of specific allergic reactions to aspirin or other NSAIDs. Certain risks, such as cardiovascular events, are explicitly stated in regulatory documents as potentially increasing with extended exposure to the medicine.

Overdose and Emergency Response

Overdose and when to seek help

This section outlines the officially documented clinical presentations and mandated emergency responses for Bravex (Ibuprofen) overdose, based strictly on regulatory prescribing information.

Property Official Regulatory Documentation Statement
Documented overdose presentations May include nausea, vomiting, stomach pain, drowsiness, ringing in the ears (tinnitus), confusion, severe headache, blurred vision, rash, and sweating.
Physiological systems affected Gastrointestinal (bleeding, ulceration, perforation), Central Nervous System (convulsions, coma), Renal (acute renal failure), Metabolic (metabolic acidosis), and Cardiovascular (hypotension, shock).
Dose-related factors In pediatric patients, consumption of Ibuprofen exceeding 400 mg/kg is associated with a significantly increased risk of toxicity.
Population-specific notes Elderly patients are at greater risk for serious gastrointestinal adverse events, including potentially fatal bleeding.
Emergency-response statements Management is limited to symptomatic and supportive treatment. Activated charcoal may be considered. No specific antidote is known.
When immediate medical help is required Seek immediate medical attention or call a Poison Control Center immediately for any suspected overdose.

Official Overdose Statements

  • Overdose may lead to severe, life-threatening complications such as coma and cardiovascular collapse.
  • Monitoring of vital signs and laboratory parameters (e.g., renal and liver function) is required in the medical setting.

The official overdose profile explicitly states that individuals must seek immediate medical attention and outlines that the required medical response is limited to supportive and symptomatic treatment, as regulatory labeling confirms the absence of a specific antidote.

Therapeutic Uses of Bravex

Bravex is indicated for the management of symptoms associated with specific health conditions, primarily focusing on its role in providing relief from inflammation and pain. It is often prescribed to individuals needing support for chronic inflammatory responses, such as those involved in certain rheumatic disorders and debilitating musculoskeletal issues. Bravex can also be utilized for the temporary control of acute, moderate-to-severe pain in situations where other standard supportive measures have been insufficient. The therapeutic objective is to facilitate an improved level of comfort and functional ability for patients experiencing these symptoms.

Quick Fact: Relief for Inflammatory Conditions and Pain Management

Eligibility and Restrictions for Use

Who Can and Cannot Use Bravex?

Eligibility for Bravex, an NSAID, is strictly defined by regulatory authorities based on patient population, age, and pre-existing medical conditions. The use of this medicine is classified as permitted, restricted, or contraindicated based on official labeling.

Absolute Contraindications

Use of this medicine is prohibited for patients with:

  • Known hypersensitivity or allergic reactions (such as asthma or hives) to Ibuprofen, aspirin, or any other NSAID.
  • Severe organ impairment, including severe heart failure (NYHA Class IV), active gastrointestinal bleeding, or severe kidney/liver disease.
  • The third trimester of pregnancy (30 weeks gestation and later).
  • Peri-operative pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Population Restrictions and Special Considerations

  • Pregnancy (20-30 weeks): Use is restricted to the lowest effective dose for the shortest duration. The medicine is permitted while breastfeeding.
  • Age: Eligibility is established for adults and pediatric patients typically 6 months of age and older. Older adults are noted as being at increased risk for adverse effects and should use the medicine with caution.
  • Cardiovascular Risk: Patients with cardiovascular disease or hypertension must use the lowest effective dose for the shortest duration to mitigate risk.

What should I know about interactions with other medicines?

Bravex Interactions with other medicines and products

The interaction profile for Bravex (Ibuprofen) is formally documented by regulatory authorities, focusing on changes in drug exposure and pharmacodynamic risk enhancement. Certain combinations are explicitly restricted or contraindicated due to clinically significant effects.


Official Restrictions and Prohibitions

  • Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 inhibitors, and Aspirin / Acetylsalicylic acid (ASA) at high daily doses is restricted or contraindicated due to the synergistic risk of severe gastrointestinal adverse events.
  • Concomitant use with Alcohol increases the potential for serious gastrointestinal adverse events, including bleeding.

Pharmacodynamic and Exposure Effects

  • Co-administration with Anticoagulants, SSRIs, and Oral Corticosteroids enhances the risk of gastrointestinal bleeding.
  • Bravex may reduce the anti-hypertensive effect of drugs like ACE inhibitors and Diuretics, and may inhibit the antiplatelet effect of low-dose Aspirin.
  • Bravex decreases the renal clearance of both Lithium and Methotrexate, leading to elevated plasma concentrations of these medicines.

Timing Constraints and Special Populations

  • A mandatory dosing interval must be observed to avoid interference with low-dose Aspirin's protective effect: Bravex must be taken at least 8 hours before or 30 minutes after the immediate-release Aspirin dose.
  • Elderly patients and those with impaired renal function are at a heightened risk of adverse events, particularly renal function deterioration, when taking interacting substances like diuretics or ACE inhibitors.

Mechanism of Action

How Bravex Works: Mechanism of Action

The mechanism of action for Bravex centers on the inhibition of Cyclooxygenase ( COX) enzymes, which constitutes the core biological mechanism through which the active ingredient influences physiological processes.


Enzyme Inhibition and Mediator Suppression

Bravex's mechanism involves the reversible, non-selective inhibition of the COX-1 and COX-2 enzymes. This action blocks the Arachidonic Acid Cascade, which is a core pathway for converting fatty acids into chemical messengers called prostaglandins (such as PGE2). Suppression of these mediators reduces the signal input for thermoregulation and decreases the sensitization state of peripheral nociceptors.


Modulation of Nociceptive and Thermoregulatory Pathways

The resulting decrease in prostaglandin levels results in two primary physiological consequences. Peripherally, the reduction in PGE2 diminishes its ability to sensitize nociceptors (pain-sensing nerves), resulting in an elevation of the nociceptive signaling threshold and contributing to the modulation of peripheral physiological responses. Centrally, the same inhibitory action within the hypothalamus allows the body's elevated temperature set-point to reset, initiating the physiological cascade for heat dissipation, which constitutes the physiological process for heat dissipation.

Dosage and Administration Information

Bravex is administered through several approved routes, including the common oral route for tablets, capsules, and suspensions, as well as the intravenous (IV), rectal, and topical routes.

Dosing regimens for oral use are established. For acute, over-the-counter (OTC) use, the dose typically ranges from 200 mg to 400 mg and must not exceed a maximum daily limit of 1200 mg. Prescription-strength regimens permit doses up to 800 mg, with a maximum total daily intake often specified as 3200 mg. The frequency for acute relief is generally every 4 to 6 hours. For the management of chronic conditions, the total daily dose is typically divided and taken three to four times a day.

Administration conditions specify that oral forms may be taken with food or milk to aid tolerability, although this is not mandatory for drug absorption. The IV formulation requires the drug to be diluted and administered as a prolonged infusion, typically over at least 30 minutes. Clinical practice involves using the medication at the lowest effective dose for the shortest duration possible across all patient groups. Dosing for children is calculated strictly based on body weight, and adults with functional impairment require the lowest possible dose. Oral tablets must be swallowed whole and should not be crushed or chewed, particularly in specialized formulations.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bravex

Evidence for Use in Acute Pain Relief

Research has extensively examined the use of Ibuprofen, the active ingredient in Bravex, in contexts related to outcomes related to physical discomfort often associated with acute, temporary issues. The core evidence stems from numerous RCTs with limited follow-up, many structured as placebo-controlled studies. These trials were primarily used in research exploring short-term symptom changes for conditions associated with acute or disruptive episodes, such as headache, dental pain, or pain following minor surgical procedures.

The studies monitored outcomes describing episodic or acute changes, specifically tracking measurements of pain intensity at defined time intervals. Findings describe patterns observed in the studies where findings indicate that participants receiving the study agent had pain intensity measurements that followed a different pattern over the predefined measurement intervals compared to the control group. Research monitored the time intervals reported by participants as they noted changes in their perceived discomfort. This body of evidence provides information regarding how outcomes related to physical discomfort were monitored in studies with limited follow-up.

Evidence for Use in Fever Reduction (Antipyresis)

Ibuprofen was evaluated in research exploring outcomes related to systemic or functional imbalance, specifically related to elevated body temperature. These studies often involved controlled trials where the agent was compared to a placebo or other was evaluated in compounds over a fixed duration of hours. The research examined outcomes monitoring physiological strain or stress, focusing on the magnitude and duration of the observed temperature change.

Studies report how symptoms evolved in the observed populations, describing a measurable difference in the course of the temperature readings between the study group and the control group over the measured intervals. Findings indicate patterns related to the length of time that changes in elevated body temperature was observed in the study populations.

Evidence for Use in Chronic Inflammatory and Musculoskeletal Conditions

The evidence for conditions marked by functional limitations, such as osteoarthritis and active arthritis, was studied for outcomes linked to inflammatory or irritative states. These studies monitored patient-reported outcomes describing perceived discomfort and used validated scales to assess changes in daily functioning or activity level, such as joint stiffness and mobility. Research describes patterns where participants' reported discomfort and functional scores were different during the study period, when compared against the control group.

Evidence in Special Populations

Ibuprofen was evaluated in specific research contexts involving distinct age groups. Studies research examined its use in pediatric patients (children) for outcomes related to systemic or functional imbalance (fever) and pain, and the existing research is extensive for those indications. The compound was evaluated in trials that included older adults, particularly those with conditions marked by functional limitations like osteoarthritis. Overall, research highlights what is known — and what is still uncertain — regarding how research explores findings related to these distinct populations in controlled studies.

What Remains Uncertain in the Research

While a significant body of research exists, several areas remain uncertain or are subject to ongoing study. Comparative evidence is limited in some contexts, meaning that direct, head-to-head comparisons against all newer or specific therapeutic alternatives are not always available. The long-term outcomes are not fully characterized for continued or highly frequent use over many months. Furthermore, data for certain groups remain insufficient, especially for populations with complex patterns of coexisting chronic diseases. Studies help show what has been observed so far, but research does not determine whether an individual will respond similarly outside the specific conditions studied in the trials.

Key Studies & References

  1. Ibuprofen - StatPearls - NCBI Bookshelf (Review of Musculoskeletal/Chronic Pain and Regulatory Context)
  2. World Health Organization Model List of Essential Medicines (Relevant for global usage/indication context)

Frequently Asked Questions (FAQ)

Common questions about Bravex (FAQ)


Q: What is the main condition Bravex is officially approved to treat?

A: Official regulatory documents state that Bravex (Ibuprofen) is approved for the temporary relief of minor aches and pains. This includes discomfort associated with headache, muscle aches, backache, arthritis, toothache, and menstrual cramps. It is also approved for the temporary reduction of fever.


Q: What is the typical time frame before a person might notice the effects of Bravex?

A: According to the official product information, Bravex is typically noted to start working relatively quickly. Most individuals may begin to notice the pain or fever-reducing effects within 30 minutes to one hour after taking the medication.


Q: Is it common to feel very tired when first starting Bravex?

A: The official product's side effect profile lists feeling tired (fatigue) and dizziness as potential effects that may occur. This information is included in the patient leaflet.


Q: What foods or supplements are generally listed as having a potential interaction with Bravex?

A: Official regulatory interaction information focuses mainly on prescription and over-the-counter medicines. Regulatory documents note that certain supplements, particularly those that may affect blood clotting, could enhance the risk of bleeding when used concurrently with Bravex.


Q: Can Bravex affect a person's ability to drive or operate machinery?

A: Official patient safety information states that due to the possibility of side effects like dizziness or feeling tired, using caution is indicated when performing tasks that require full concentration, such as driving or operating heavy machinery.


Q: Is Bravex known to interact with birth control pills or other hormonal medications?

A: Formal interaction lists in regulatory documents do not typically include a clinical interaction between Bravex and standard combined hormonal birth control pills or patches. The full product monograph provides a complete list of known interactions.


Q: What kind of monitoring (e.g., blood tests) might be necessary while taking Bravex?

A: For patients who are prescribed long-term or high-dose treatment, official guidance advises doctors to carefully assess risk factors. This assessment may involve monitoring of blood pressure, kidney function, and liver function to manage potential systemic effects.


Q: Is Bravex a medication that must be taken long-term, according to current evidence?

A: Official guidelines emphasize limiting the duration of use to the shortest time necessary. Over-the-counter labels for Bravex state that it should not be taken for more than 10 days for pain or 3 days for fever, unless a healthcare professional has been consulted.


Q: Are there any specific lifestyle factors (like smoking or caffeine) that are mentioned in relation to Bravex?

A: Official regulatory documents mention smoking as a risk factor that should be assessed by doctors before long-term or high-dose Bravex treatment is initiated. This assessment is due to smoking's established association with cardiovascular risks.


Q: What is the 'Black Box Warning' (if any) associated with Bravex?

A: The US Food and Drug Administration (FDA) label for Bravex contains a Boxed Warning, sometimes referred to as a Black Box Warning. This warning highlights the risk of serious cardiovascular events (such as heart attack and stroke) and serious gastrointestinal events (including bleeding and ulcers).


Q: Does taking Bravex affect the results of any common lab tests?

A: The regulatory label notes that taking Bravex may cause temporary, minor elevations in certain liver enzyme tests. It also notes the drug’s potential to affect platelet function.


Q: What is the main mechanism of action of Bravex, as described in simple terms?

A: Bravex works by preventing the body from making specific chemical signals called prostaglandins, which are responsible for causing pain, fever, swelling, and redness. In simple terms, this action targets the source of inflammation and discomfort. The medicine is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID).


Q: Is it true that Bravex has a known interaction with dairy products?

A: No, official administration conditions state that oral forms of Bravex may be taken with food or milk. This guidance indicates that dairy products do not have a known interaction that affects the drug's effectiveness or absorption.


Q: How soon after stopping Bravex do the effects on the body usually wear off?

A: Based on the drug's pharmacokinetic profile, Bravex is metabolized and eliminated from the body relatively quickly. Official information indicates the medicine is almost fully removed from the body within about 10 hours after the last dose.


Q: Are there specific instructions for what to do if a dose of Bravex is missed?

A: Official patient instructions describe a standard approach where the dose is taken when next needed for pain relief. The instructions specifically state that a person should not take a double dose to make up for the missed one.


Q: What are the common signs of an allergic reaction to Bravex that require immediate medical attention?

A: Regulatory warnings list specific signs of a severe allergic reaction, which include hives, facial swelling, asthma (wheezing), and the development of a rash or blisters. Official documents indicate that these symptoms require immediate medical attention.


Q: What is the maximum amount of time Bravex was studied in clinical trials?

A: While studies examine various durations, regulatory guidance emphasizes using the medicine for the shortest duration necessary to achieve the desired effect. The over-the-counter label specifically limits use for pain to a maximum of 10 days without consulting a physician.


Q: What is the official definition of the condition that Bravex treats?

A: Bravex is formally described as relieving the symptoms of pain, fever, and inflammation, which are key symptoms associated with various conditions. These conditions are officially listed as headache, minor pain of arthritis, dental pain, and muscular aches.


Q: Can Bravex be taken with antacids or acid-reducing medications?

A: Formal drug interaction information does not typically list a clinical interaction between Bravex and common antacids. The regulatory label emphasizes that caution is indicated for individuals with a history of stomach or gastrointestinal issues when using NSAIDs.


Q: What is the typical time of day recommended for taking Bravex?

A: Official dosing instructions specify the interval between doses, such as every 4 to 6 hours, rather than a fixed time of day like morning or night. For chronic conditions, guidance emphasizes that the total daily dose should be divided and taken consistently throughout the day.


Q: Is Bravex manufactured as a generic version, or is it only available as a brand name?

A: The active ingredient in Bravex is Ibuprofen. Official regulatory information confirms that Ibuprofen is the widely available generic name and is manufactured in FDA-approved generic formulations that are considered bioequivalent to the brand-name product.


Q: What are the official sources of patient information for Bravex, like the medication guide?

A: Official patient information materials, such as the Medication Guide, Patient Information Leaflet, and Drug Facts Label, can be accessed through government regulatory websites. These include the FDA's DailyMed service and the NIH's MedlinePlus drug information resources.


Q: Is Bravex a controlled substance or scheduled medication?

A: Bravex (Ibuprofen) as a single ingredient is not classified as a controlled substance by the US Drug Enforcement Administration (DEA). However, it is noted that combination products that include Ibuprofen along with certain opioid pain relievers are classified as scheduled medications.


Q: What should be done if a user experiences a minor, non-emergency side effect from Bravex?

A: Official patient information states that a healthcare provider should be contacted if any side effects are bothersome or persist over time. If symptoms are severe or signs of an allergic reaction occur, instructions indicate that stopping use and seeking medical attention immediately is necessary.

How should Bravex be stored and disposed of?

Official Storage and Disposal Profile for Bravex

The storage of Bravex (Ibuprofen) is strictly defined by regulatory requirements to ensure product stability and safety. The medicine must be stored at a controlled room temperature, typically between 20 C and 25 C.

Storage and Handling Constraints

Requirement Constraint
Temperature Store below 30 C and do not freeze the oral suspension.
Protection Must be protected from excessive heat and moisture.
Container Keep in the original container and keep it tightly closed.

Disposal Instructions

Bravex must be stored out of the reach of children and pets. Unused or expired medication should be disposed of through an official drug take-back program. If a program is unavailable, the medicine must be secured and mixed with an unappealing substance before disposal in the household trash. The product should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bravex found in:

A-Z Index: